Synthesis, Acoustic Stability, and Pharmacologic Activities of Papaverine-Loaded Echogenic Liposomes for Ultrasound Controlled Drug Delivery

References

• H. Alkan-Onyuksel, S. M. Demos, G. M. Lanza, M. J. Vonesh, M. E. Klegerman, B. J. Kane, J. Kuszak, and D. D. McPherson. (1996). Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 85:486–90.
   PubMed Web of Science ®Google Scholar
• T. M. Allen. (1998). Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 56:747–56.
   PubMed Web of Science ®Google Scholar
• N. Andaluz, T. A. Tomsick, J. M. TewJr., H. R. van Loveren, H. S. Yeh, and M. Zuccarello. (2002). Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: Experience at the University of Cincinnati. Surg Neurol 58:131–8.
   PubMedGoogle Scholar
• C. C. Coussios, C. K. Holland, L. Jakubowska, S. L. Huang, R. C. MacDonald, A. Nagaraj, and D. D. McPherson. (2004). In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz. Ultrasound Med Biol 30:181–90.
   PubMed Web of Science ®Google Scholar
• J. Fandino, Y. Kaku, B. Schuknecht, A. Valavanis, and Y. Yonekawa. (1998). Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. Journal of Neurosurgery 89:93–100.
   PubMed Web of Science ®Google Scholar
• K. Firlik, A. Kaufmann, A. Firlik, C. Jungreis, and H. Yonas. (1999). Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surgical Neurology 51:66–74.
   PubMedGoogle Scholar
• D. W. Fry, J. C. White, and I. D. Goldman. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90:809–15.
   PubMed Web of Science ®Google Scholar
• A. Hamilton, S. L. Huang, D. Warnick, A. Stein, M. Rabbat, T. Madhav, B. Kane, A. Nagaraj, M. Klegerman, R. McDonald, and D. McPherson. (2002). Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: Studies in a new experimental model. Circulation 105:2772–8.
   PubMed Web of Science ®Google Scholar
• A. J. Hamilton, S. L. Huang, and et al (2004). Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 43:453–60.
   PubMed Web of Science ®Google Scholar
• S. Huang, D. D. McPherson, and R. C. MacDonald. (2007). Multi-functional echogenic liposomes for image-guided and ultrasound-controlled PPAR agonist delivery. J Am Coll Cardiol 49:365A.
   Web of Science ®Google Scholar
• S. L. Huang, A. J. Hamilton, A. Nagaraj, S. D. Tiukinhoy, M. E. Klegerman, D. D. McPherson, and R. C. MacDonald. (2001). Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci 90:1917–26.
   PubMed Web of Science ®Google Scholar
• S. L. Huang, and R. C. MacDonald. (2004). Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 1665:134–41.
   PubMed Web of Science ®Google Scholar
• R. Juliano, and D. Layton. (1980): Drug delivery systems: Characteristics and biomedical applications. London: Oxford University Press, 189–236.
   Google Scholar
• N. F. Kassell, G. Helm, N. Simmons, C. D. Phillips, and W. S. Cail. (1992). Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77:848–52.
   PubMed Web of Science ®Google Scholar
• J. A. Kopechek, T. M. Abruzzo, B. Wang, S. M. Chrzanowski, D. A. Smith, P. Kee, S. Huang, J. Collier, D. D. McPherson, and C. K. Holland. (2008). Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes. J Ultrasound Med In Press
   PubMed Web of Science ®Google Scholar
• H. M. Liu, and Y. K. Tu. (2002). The efficacy of papaverine administration by different routes for the treatment of experimental acute cerebral vasospasm. J Clin Neurosci 9:561–5.
   PubMed Web of Science ®Google Scholar
• J. K. Liu, M. S. Tenner, O. N. Gottfried, E. A. Stevens, J. M. Rosenow, N. Madan, J. D. MacDonald, J. R. Kestle, and W. T. Couldwell. (2004). Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 100:414–21.
   PubMed Web of Science ®Google Scholar
• R. S. Meltzer, E. G. Tickner, and R. L. Popp. (1980). Why do the lungs clear ultrasonic contrast?. Ultrasound Med Biol 6:263–9.
   PubMed Web of Science ®Google Scholar
• J. Milburn, C. Moran, D. Cross, M. Diringer, T. Pilgrim, and R. Dacey. (1998). Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 88:38–42.
   PubMed Web of Science ®Google Scholar
• H. Minami, K. Kuwamura, and N. Tamaki. (2001). Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm. Kobe J Med Sci 47:169–79.
   PubMedGoogle Scholar
• K. Mizushige, I. Kondo, K. Ohmori, K. Hirao, and H. Matsuo. (1999). Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure. Ultrasound Med Biol 25:1431–7.
   PubMed Web of Science ®Google Scholar
• R. J. OskouianJr., N. A. Martin, J. H. Lee, T. C. Glenn, D. Guthrie, N. R. Gonzalez, A. Afari, and F. Vinuela. (2002). Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 51:30–43.
   PubMed Web of Science ®Google Scholar
• J. W. Park, C. C. Benz, and F. J. Martin. (2004). Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin Oncol 31:196–205.
   PubMed Web of Science ®Google Scholar
• T. M. Porter, D. A. Smith, and C. K. Holland. (2006). Acoustic techniques for assessing the Optison destruction threshold. J Ultrasound Med 25:1519–29.
   PubMed Web of Science ®Google Scholar
• R. Scroop, G. W. Britz, and G. A. West. (2004): Endovascular Therapy for Vasospasm Associated with Subarachnoid Hemorrhage. Management of Cerebral Aneurysms. HR Winn and P LeRoux. Philadelphia: Saunders: 489–498.
   Google Scholar
• D. A. Smith, T. M. Porter, J. Martinez, S. Huang, R. C. MacDonald, D. D. McPherson, and C. K. Holland. (2007). Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol 33:797–809.
   PubMed Web of Science ®Google Scholar
• D. A. B. Smith, S. Vaidya, J. A. Kopechek, and C. K. Holland. (2007). Echogenic liposomes loaded with recombinant tissue-type plasminogen activator (rt-PA) for image-guided, ultrasound-triggered drug release. J Acoust Soc Am 122:3007.
   Google Scholar
• T. P. Smith, and D. S. Enterline. (2000). Endovascular treatment of cerebral vasospasm. J Vasc Interv Radiol 11:547–59.
   PubMed Web of Science ®Google Scholar
• J. Srinivasan, J. Eskridge, M. S. Grady, D. W. Newell, and H. R. Winn. (2002). Endovascular therapy for vasospasm. Clin Neurosurg 49:261–73.
   PubMedGoogle Scholar
• J. Szebeni, J. L. Fontana, N. M. Wassef, P. D. Mongan, D. S. Morse, D. E. Dobbins, G. L. Stahl, R. Bunger, and C. R. Alving. (1999). Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99:2302–9.
   PubMed Web of Science ®Google Scholar
• K. Tachibana, and S. Tachibana. (1995). Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 92:1148–50.
   PubMed Web of Science ®Google Scholar
• S. D. Tiukinhoy, A. A. Khan, S. Huang, M. E. Klegerman, R. C. MacDonald, and D. D. McPherson. (2004). Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol 39:104–10.
   PubMed Web of Science ®Google Scholar
• S. D. Tiukinhoy-Laing, S. Huang, M. Klegerman, C. K. Holland, and D. D. McPherson. (2007). Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 119:777–84.
   PubMed Web of Science ®Google Scholar
• E. C. Unger, T. P. McCreery, R. H. Sweitzer, V. E. Caldwell, and Y. Wu. (1998). Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent. Invest Radiol 33:886–92.
   PubMed Web of Science ®Google Scholar
• P. Vajkoczy, P. Horn, C. Bauhuf, E. Munch, U. Hubner, D. Ing, C. Thome, C. Poeckler-Schoeninger, H. Roth, and P. Schmiedek. (2001). Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 32:498–505.
   PubMed Web of Science ®Google Scholar
• K. M. Wasan, and G. Lopez-Berestein. (1995). The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol Immunotoxicol 17:1–15.
   PubMed Web of Science ®Google Scholar
• Y. Z. Zhao, H. D. Liang, X. G. Mei, and M. Halliwell. (2005). Preparation, characterization and in vivo observation of phospholipid-based gas-filled microbubbles containing hirudin. Ultrasound Med Biol 31:1237–43.
   PubMed Web of Science ®Google Scholar